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Abstract
© Springer Science+Business Media New York 2015. All right reserved. Design of drug with
prolonged therapeutic action is one of the rapid developing fields of modern medical science
and required implementation of different methods of protein chemistry and molecular biology.
There are several therapeutic proteins needing increasing of their stability, pharmacokinetic,
and  pharmacodynamics  parameters.  To  make  long-live  DNA-encoded drug  PEGylation  was
proposed.  Alternatively  polysialic  (colominic)  acid,  extracted  from the  cell  wall  of  E.  coli,
fractionated to the desired size by anionexchange chromatography and chemically activated to
the  amine-reactive  aldehyde  form,  may  be  chemically  attached  to  the  polypeptide  chain.
Conjugates  of  proteins  and  polysialic  acid  generally  resemble  properties  of  protein-  PEG
conjugates, but possess significant negative net charge and are thought to be fully degradable
after endocytosis due to the presence of intracellular enzymes, hydrolyzing the polysialic acid.
Complete biodegradation of the polysialic acid moiety makes this kind of conjugates preferable
for creation of drugs, intended for chronic use. Here, we describe two different protocols of
chemical  polysialylation.  First  protocol  was  employed  for  the  CHO-derived  human
butyrylcholinesterase with optimized for recovery of specific enzyme activity. Polysialic acid
moieties are attached at various lysine residues. Another protocol was developed for high-yield
conjugation of human insulin; major conjugation point is the N-terminal residue of the insulin's
light chain. These methods may allow to produce polysialylated conjugates of various proteins
or polypeptides with reasonable yield and without significant loss of functional activity.
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